Cat: MO-NAB-00879W
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
- Product Details
Specifications
| Host species | Human (Homo sapiens) |
| Species Reactivity | SARS-CoV-2; SARS-COV |
| Clone | NW0802 |
| Specificity | Recognize SARS-CoV-2 RBD protein |
| Immunogen | Recombinant SARS-CoV-2 RBD protein |
| Format | Liquid |
| Buffer | PBS, pH7.5 |
| Storage | Store at 2 to 8°C for one week. From the date of receipt, store at -20 to -80 °C for 12 months. Avoid repeated freeze-thaw cycles. |
Application Information
| Application | WB, ELISA |
| Application Notes | WB: 1:1000-2000 Elisa: 1:5000-1:10000 |
Target
| Introduction | Coronavirus disease 2019 is a newly emerging infectious disease that is currently spreading globally. It is caused by a new type of coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The spike (S) protein of SARS-CoV-2 plays a key role in the process of receptor recognition and cell membrane fusion, and is composed of two subunits S1 and S2. The S1 subunit contains a receptor binding domain that recognizes and binds to the host receptor angiotensin converting enzyme 2, while the S2 subunit mediates viral cell membrane fusion by forming a six-helix bundle through two heptapeptide repeat domains. In this review, we focused on the latest research progress in the structure, function and development of antiviral drugs targeting S protein. |
| Product Overview | Recombinant anti-SARS-CoV-2 RBD antibody is expressed from XtenCHO |
| Alternative Names | Anti Spike glycoprotein antibody; Anti 2019-nCoV RBD antibody; Anti 2019-nCoV Spike RBD antibody |
For Research Use Only | Not For Clinical Use.